Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
CENA AKCJI
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionLinscomb & Williams, Inc.
Latest Disclosed Ownership1,804 shares
Latest Disclosed Value $ 275,561
Linscomb & Williams, Inc. ownership in NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 11, 2026 - Linscomb & Williams, Inc. filed a 13F-HR form disclosing ownership of 1,804 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $231,814 USD as of March 31, 2026. The entity filed a previous 13F-HR on May 11, 2023 disclosing 0 shares of Novartis AG - Depositary Receipt (Common Stock). The current value of the position is $218,284 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,804 1,804 276 0.0123
2023-05-11 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 0 -3,437 -100.00 0 -100.00
2023-02-14 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,437 3,437 312 0.0158
2022-08-12 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 0 -3,437 -100.00 0 -100.00
2022-05-17 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,437 191 5.88 301 5.99 0.0144
2022-02-10 2021-12-31 13F NOVARTIS COM 66987V109 3,246 -2 -0.06 284 6.77 0.0136
2021-11-03 2021-09-30 13F NOVARTIS COM 66987V109 3,248 40 1.25 266 -9.22 0.0137
2021-08-10 2021-06-30 13F NOVARTIS COM 66987V109 3,208 -177 -5.23 293 1.38 0.0150
2021-05-12 2021-03-31 13F NOVARTIS AG COM 66987V109 3,385 -92 -2.65 289 -11.89 0.0157
2021-02-11 2020-12-31 13F NOVARTIS COM 66987V109 3,477 46 1.34 328 10.07 0.0196
2020-11-13 2020-09-30 13F NOVARTIS COM 66987V109 3,431 -28 -0.81 298 -1.32 0.0205
2020-08-11 2020-06-30 13F NOVARTIS COM 66987V109 3,459 -148 -4.10 302 1.68 0.0221
2020-05-11 2020-03-31 13F NOVARTIS A G COM 66987V109 3,607 905 33.49 297 16.02 0.0262
2020-02-13 2019-12-31 13F NOVARTIS A G COM 66987V109 2,702 13 0.48 256 9.40 0.0167
2019-11-08 2019-09-30 13F NOVARTIS A G COM 66987V109 2,689 84 3.22 234 -1.68 0.0188
2019-08-06 2019-06-30 13F NOVARTIS A G COM 66987V109 2,605 143 5.81 238 0.42 0.0195
2019-05-09 2019-03-31 13F NOVARTIS A G COM 66987V109 2,462 0 0.00 237 12.32 0.0199
2019-02-08 2018-12-31 13F NOVARTIS A G COM 66987V109 2,462 0 0.00 211 -0.47 0.0200
2018-11-08 2018-09-30 13F NOVARTIS A G COM 66987V109 2,462 -185 -6.99 212 6.00 0.0174
2018-08-07 2018-06-30 13F NOVARTIS A G COM 66987V109 2,647 2,647 200 0.0170
2018-05-04 2018-03-31 13F NOVARTIS A G COM 66987V109 0 -2,479 -100.00 0 -100.00
2018-02-02 2017-12-31 13F NOVARTIS A G COM 66987V109 2,479 -73 -2.86 208 -5.02 0.0171
2017-10-27 2017-09-30 13F NOVARTIS A G COM 66987V109 2,552 -170 -6.25 219 -3.52 0.0188
2017-08-15 2017-06-30 13F NOVARTIS A G COM 66987V109 2,722 2,722 227 0.0203
2017-02-07 2016-12-31 13F NOVARTIS A G COM 66987V109 0 -2,647 -100.00 0 -100.00
2016-11-10 2016-09-30 13F NOVARTIS A G COM 66987V109 2,647 156 6.26 209 1.46 0.0203
2016-08-05 2016-06-30 13F NOVARTIS A G COM 66987V109 2,491 2,491 0.00 206 0.0208
2016-01-29 2015-12-31 13F NOVARTIS A G COM 66987V109 0 -2,252 -100.00 0 -100.00
2015-11-09 2015-09-30 13F NOVARTIS A G COM 66987V109 2,252 83 3.83 207 -2.82 0.0243
2015-08-05 2015-06-30 13F NOVARTIS A G COM 66987V109 2,169 2,169 -77.57 213 -71.29 0.0233
2014-02-05 2013-12-31 13F Novartis COM 66987V109 0 -9,669 -100.00 0 -100.00
2013-11-01 2013-09-30 13F Novartis COM 66987V109 9,669 -600 -5.84 742 2.20 0.0973
2013-08-01 2013-06-30 13F Novartis COM 66987V109 10,269 10,269 726 0.0993
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.